Sibannac Expands into Booming $1.4 Trillion Wellness Tourism Market with Starwalker Journeys

In This Article:

SCOTTSDALE, AZ / ACCESS Newswire / March 11, 2025 / Sibannac, Inc. (OTC PINK:SNNC), a Nevada corporation (the "company"), is strategically expanding into the high-growth wellness tourism sector with its Starwalker Journeys-a series of luxury, transformational retreats combining consciousness exploration, psychedelic wellness, and curated travel experiences. Partnering with William Henry , investigative mythologist and Ancient Aliens host, Sibannac is poised to lead the next wave of high-end wellness retreats.

The Explosive Growth of Wellness & Psychedelic Tourism

According to the Global Wellness Institute , wellness tourism is expected to grow from $651 billion in 2022 to $1.4 trillion by 2027-nearly twice the rate of conventional tourism. With travelers seeking deeply immersive health and healing experiences, brands like Sibannac are perfectly positioned to capitalize on this trend.

At the same time, psychedelic retreats are rapidly emerging as a dominant force in the wellness industry. A recent Vogue article reveals that luxury plant-medicine retreats are attracting an elite clientele-including CEOs, high-net-worth individuals, and wellness seekers-who are willing to invest thousands for guided, legal psychedelic experiences.

  • Industry Insight: The average cost of a high-end psychedelic retreat ranges from $5,000 to $15,000 per guest, making it one of the most profitable wellness tourism segments. (Vogue)

  • Market Expansion: The global psychedelic market is projected to grow from $3.8 billion in 2023 to $10.7 billion by 2027, driven by shifting regulations and rising demand. (Global Wellness Institute)

  • Legalization & Accessibility: Countries like Costa Rica, Portugal, Peru, Mexico and Jamaica already allow use of some psychedelics like Ayahuasca and Psilocybin (Magic Mushrooms) and have decriminalized others for personal use. In the U.S., Oregon has legalized Psilocybin through licensed centers, where over 8,000 people have already legally consumed psychedelic mushrooms in a controlled setting with great success. Colorado has passed similar legislation where Psilocybin centers will begin to provide mushroom journeys in 2025. Arizona has passed legislation to continue to study mushroom therapy and has approved MDMA, contingent upon FDA rescheduling.

"We are witnessing a complete shift in how people approach health, healing, and consciousness," said David Mersky, CEO of Sibannac . "Starwalker Journeys isn't just about travel-it's about transformation. We're providing a structured, high-end experience for seekers who want safe, expert-guided psychedelic wellness retreats in the most breathtaking destinations."